ImageneBio, Inc. (IMA) vs Lite Strategy, Inc. (LITS)
ImageneBio, Inc. and Lite Strategy, Inc. are both Biotechnology companies. ImageneBio, Inc. and Lite Strategy, Inc. are of similar size ($52.9M and $51.0M). Lite Strategy, Inc. grew revenue faster over the last twelve months: 152.9% against −68.0%. Across the 14 metrics below, ImageneBio, Inc. leads on 7 and Lite Strategy, Inc. on 7.
Valuation
Profitability
| Metric | IMA | LITS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (41.34%) | (159.26%) | (57.72%) |
| Return on assets | (38.34%) | (154.82%) | (49.22%) |
| Return on invested capital | (622.37%) | (73.66%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack